May Lower RFR Signal Repeat Revascularization? - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

May Lower RFR Signal Repeat Revascularization?

Patients with lower nonischemic resting full-cycle ratio values had more repeat revascularizations despite similar 2-year major cardiovascular event rates.

  • By

  • Andrea Surnit

  • July 28, 2026

  • 4 min

Share

  • 1

    Deferring coronary revascularization based on nonischemic resting full-cycle ratio (RFR) may lead to favorable 2-year cardiovascular outcomes.

  • 2

    Patients with lower nonischemic RFR values underwent repeat revascularization more frequently compared to those with higher values.

  • 3

    The study evaluated 773 patients with 1,012 angiographically intermediate coronary lesions from 2016 to 2022.

  • 4

    At 2 years, the lesion-based major adverse cardiovascular event (MACE) rate was 8%, with no significant differences across RFR groups.

  • 5

    Chronic obstructive pulmonary disease was independently associated with higher rates of MACE following multivariable adjustment.

Original Source(s)

May Lower RFR Signal Repeat Revascularization?

  • by Andrea Surnit

  • July 28, 2026

Related Content

ASE Details M-TEER Imaging Guidance

The guideline emphasizes standardized image orientation and heart team communication during mitral valve transcatheter edge-to-edge repair.

Hemodynamic Instability in Intubation May Be Predictable

Narrative review describes how physiologic stressors accumulate from induction through postintubation care and may contribute to cardiovascular deterioration during airway management.

Can Sugammadex Lower Postsurgical Pulmonary Complications?

A large international randomized trial found fewer postoperative pulmonary complications with sugammadex vs. neostigmine following major abdominal or thoracic surgery, although the difference was driven primarily by reduced atelectasis.